Jeffrey P. Meyers

International validation of the consensus Immunoscore for the classification of colon cancer: a prognostic and accuracy study

Franck Pagès, Bernhard Mlecnik, Florence Marliot et al. · The Lancet · 2018 · 2K citations

Prognostic Biomarkers, Oncology, International Validation +12

Duration of Adjuvant Chemotherapy for Stage III Colon Cancer

Axel Grothey, Alberto Sobrero, Anthony F. Shields et al. · New England Journal of Medicine · 2018 · 1.1K citations · Full text

Prognosis of patients with peritoneal metastatic colorectal cancer given systemic therapy: an analysis of individual patient data from prospective randomised trials from the Analysis and Research in Cancers of the Digestive System (ARCAD) database

Jan Franko, Qian Shi, Jeffrey P. Meyers et al. · The Lancet Oncology · 2016 · 628 citations

Gastrointestinal Oncology, Individual Patient Data, Medicine +9

Regorafenib dose-optimisation in patients with refractory metastatic colorectal cancer (ReDOS): a randomised, multicentre, open-label, phase 2 study

Tanios Bekaii‐Saab, Fang‐Shu Ou, Daniel H. Ahn et al. · The Lancet Oncology · 2019 · 270 citations · Full text

Gastrointestinal Oncology, Medicine, Cancer Management +7

Effect of duration of adjuvant chemotherapy for patients with stage III colon cancer (IDEA collaboration): final results from a prospective, pooled analysis of six randomised, phase 3 trials

Thierry André, Jeffrey A. Meyerhardt, Timothy Iveson et al. · The Lancet Oncology · 2020 · 270 citations

Gastrointestinal Oncology, Medicine, Cancer Management +8